Construction Spending in

California

California’s biopharmaceutical companies research and develop new treatments and cures that improve patient health while also contributing to U.S. economic health. These companies employ highly skilled union construction workers to build state-of-the-art research and manufacturing facilities to ensure infrastructure is built to exacting standards.

Construction Employment

Union Labor & Earnings, 2012–17

Pharmaceutical & Biotech

13.8

million

Labor Hours Demanded

(14 trades, installation, and maintenance)

4.8

million

Union Labor Hours (est)

(State union% in non-residential = 34.8%)

$28.47

Average Union Wage

(Union construction workers, 2017 dollars)

$136.7

million

Total Union Earnings (est.)

(Union hours times average wage)

Industry Analysis: California

Pharmaceutical Manufacturing (2017)

Firms

581

Firms

Employees

52,125

Employees

Annual Wages

$7.7

billion

Annual Wages

California Construction Labor Hours by Trade

Pharmaceutical & Biotech, 2012–17

110,575

Installation

58,476

Maintenance

169,051

Total hours

Largest Construction Projects

Pharmaceutical & Biotech Manufacturing, 2012–17

Gilead Sciences Incorporated

La Verne Grassroot Sterile Intravenous Therapeutics Plant

La Verne, California

500,000,000

2015–2017

Scripps Research Institute

La Jolla Scripps Cardiovascular Institute Addition

La Jolla, California

456,000,000

2011-2014

Gilead Sciences Incorporated

Foster City Ranolazine Phase 3 & Other Cardiovascular NB 324 R&D Bldg Addition

Foster City, CA

300,000,000

2016-2020

HCP, Incorporated Life Sciences

South San Francisco The Cove at Oyster Point R&D Buildings Phase III

South San Francisco

220,000,000

2017-2018

Boehringer Ingelheim BioXcellence CMO

Fremont Mammalian Cell Culture Antibodies & Biosimilars CMO Reno/Equip Upgrade

Fremont, CA

217,000,000

2017-2018

Gilead Sciences Incorporated

Foster City Biopharmaceutical R&D Laboratory and Pilot Lab/Plant Addition

Foster City, CA

200,000,000

2013-2015

Genentech (Roche USA) Incorporated

Oceanside Biopharmaceuticals P2 Downstream (Purification Suite) Upfit

Oceanside, CA

180,000,000

2015-2017

HCP, Incorporated

South San Francisco Grassroot The Cove at Oyster Point R&D Buildings

South San Francisco, CA

170,000,000

2015-2016

HCP, Incorporated Life Sciences

South San Francisco The Cove at Oyster Point R&D Buildings Phase II

South San Francisco, CA

160,000,000

2016-2017

Genentech (Roche USA) Incorporated

Vacaville Cell Culture Plant CCP2 Debottlenecking, Validation & Commissioning

Vacaville, CA

153,000,000

2013-2016

Gilead Sciences Incorporated

La Verne Grassroot Sterile Intravenous Therapeutics Plant

La Verne, California

Location

500,000,000

Project Value

2015–2017

Years

Take Action

Share the study results and spread the word about the connection between the biopharmaceutical industry and union construction workers in California!

You may be surprised by the connection between California’s biopharmaceutical industry and union labor. A new study finds that from 2012-2017 America’s biopharmaceutical companies invested nearly $7 billion in infrastructure in the state, creating 4.8 million union labor hours. View California’s labor-industry profile here: https://unionjobs.pilma.org/unionjobs/ca/

California’s pharmaceutical companies and the building trades unions have a surprising relationship - a new study finds that from 2012-2017 biopharmaceutical companies invested nearly $7 billion in infrastructure in the state, creating 4.8 million union labor hours. View California’s labor-industry profile here: https://unionjobs.pilma.org/unionjobs/ca/

A new study finds that from 2012-2017 California’s biopharmaceutical companies invested nearly $7 billion in infrastructure in the state, creating 4.8 million union labor hours. Learn more: https://unionjobs.pilma.org/unionjobs/ca/